Cross-functional team of healthcare professionals

We’re your partner in safety

We are committed to supporting opioid stewardship initiatives.

According to the Institute for Safe Medication Practices, opioid stewardship may be described as “coordinated interventions designed to improve, monitor, and evaluate the use of opioids in order to support and protect human health.” 1

Opioid stewardship is a concept that emerged only recently and is modeled after the antimicrobial stewardship programs that have been widely implemented and are now required for Joint Commission-accredited hospitals and nursing care centers.2

The Joint Commission revised their pain standards in 2018 to include leadership standard: “A hospital has a leader or leadership team that is responsible for pain management and safe opioid prescribing and develops and monitors performance improvement activities.”3

One initiative of Opioid Stewardship is drug diversion. The availability of more precise clinically relevant vial and pre-filled syringe sizes may help address diversion by limiting the need for product waste and related documentation.4

Fresenius Kabi supports leadership efforts for implementing hospital-wide opioid stewardship.

Opioid stewardship in a hospital has been focused on discharge orders and prescribing of limited opiates, education, and establishing treatment protocols for OUD (opioid use disorder). Below are additional initiatives for consideration to improve pain management before surgical procedures.

Pain assessment and management standards

On January 1, 2018, The Joint Commission released its updated pain assessment and management standards. The requirements outline a multi-level approach to pain management to help frontline staff and clinicians deliver safe, individualized pain care. This page is designed to assist users in standard interpretation and provide resources on the topic of pain assessment and management.

Implementing ERAS protocols

Enhanced recovery after surgery (ERAS) protocols are multimodal perioperative care pathways designed to achieve early recovery after surgical procedures by maintaining preoperative organ function and reducing the profound stress response following surgery.

Administering multimodal strategies

A multimodal approach may decrease the use of opioids and associated side effects (e.g., delirium, and respiratory depression), tolerance, and diversion.5,6,7 Second, a multimodal approach may be a more effective pain control strategy, potentially decreasing the complications associated with suboptimal pain control, such as pneumonia, deep venous thrombosis, and postoperative cognitive dysfunction.5,6,7

Employing Perioperative Surgical Home

Perioperative Surgical Home is a patient-centric, team-based model of care created by leaders within the American Society of Anesthesiologists to help meet the demands of a rapidly approaching health care paradigm that will emphasize gratified providers, improved population health, reduced care costs, and satisfied patients.

Minimizing controlled substance waste streams

Waste may include products expiring, products prepared for administration but not administered to the patient (e.g., when a physician discontinues or a patient refuses administration), and drug product remaining after a partial dose is removed from its packaged unit.8 Controlled substances that are stocked in as ready-to-use form as possible8 and in optimal product sizes may help reduce medication waste.4

Addressing institutional drug diversion

Drug diversion can be defined as any criminal act or deviation that removes a prescription drug from its intended path.8 It is estimated that approximately 10% to 15% of all healthcare professionals will misuse drugs or alcohol at some time during their career.9 Controlled substances diversion in health systems can lead to serious patient safety issues, harm to the diverter, and significant liability risk to the organization.8 Optimizing product size may help minimize waste, risk of drug diversion, and costs accordingly.4

Our commitment to minimizing the risk of diversion opportunities.

Omnicell® and Fresenius Kabi have teamed up to provide customers more flexibility with their medication supply chain and enhanced controlled substance management initiatives.

Through this collaboration, cassettes within the Controlled Substance Dispenser (CSD) provide health systems with a secure way to store and dispense Simplist® MicroVault® prefilled syringes.

Multiple levels of security for controlled substance dispensing.

  • Single dose dispensing helps improve patient safety and nurse efficiency while supporting diversion control
  • Increases control and security of controlled substances, high-risk, and high-value medications
  • Can eliminate the need for nurse countback, reducing steps in medication administration process & supports inventory accuracy